Predicting recurrence following curative surgery in stage I non-small cell lung cancer patients using an angiogenesis-associated factor

Journal of Experimental and Clinical Cancer Research

Volumn 26, Issue 3, 2007, Pages 301-305

  Ohta, Y ^a   Tanaka, Y ^b   Watanabe, G ^b   Minato, H ^b  

^a NATIONAL HOSPITAL ORGANIZATION KANAZAWA MEDICAL CENTER   (Japan)

^b KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Stage I NSCLC; VEGF

Indexed keywords

VASCULOTROPIN A; VASCULOTROPIN C;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LOBECTOMY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RECURRENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 35348826051     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Mattern J., Koomagi R., Volm M.: Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid lung carcinoma. Br. J. Cancer 73: 931-934, 1996.
2. Fontanini G., Faviana P., Lucchi M., et al.: A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavorable prognosis in operated small cell lung carcinoma. Br. J. Cancer 86: 558-563, 2002.
3. Yuan A., Yu C.J., Kou S.H., et al.: Vascular endothelial growth factor 189 mRNA isoform expression specifically sorrelates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer. J. Clin. Oncol. 19: 432-441, 2001.
4. Herbst R.S., Onn A., Sandler A.: Angiogenesis and lung cancer: Prognostic and therapeutic implications. J. Clin. Oncol. 23: 3243-3256, 2005.
5. Han H., Silverman J.F., Santucci T.S., et al.: Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis. Ann. Surg .Oncol. 8: 72-79, 2001.
6. Ogawa E., Takenaka K., Yanagihara K., et al.: Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients. Br. J. Cancer 91: 498-503, 2004.
7. Kojima H., Shijubo N., Yamada G., et al.: Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma. Cancer 104: 1668-1677, 2005.
8. Renyi-Vamos F., Tovari J., Fillinger J., et al.: Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer. Clin. Cancer Res. 11: 7344-7353, 2005.
9. Ohta Y., Nozawa H., Tanaka Y., Oda M., Watanabe Y.: Increased vascular endothelial growth factor and vascular endothelial growth factor-C and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 119: 804-813, 2000.
10. Ohta Y., Oda M., Wu J., et al.: Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis. J. Thorac. Cardiovasc. Surg. 122: 900-906, 2001.
11. Ohta Y., Nozaki Z., Nozawa H., et al.: The predictive value of vascular endothelial growth factor and nm23 for the diagnosis of occult metastasis in non-small cell lung cancer. Jpn. J. Cancer Res. 92: 361-366, 2001.
12. Ohta Y., Endo Y., Tanaka M., et al.: Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin. Cancer Res. 2: 1411-1416, 1996.
13. Folkman J.: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1: 27-31, 1995.
14. Ohta Y., Tomita Y., Oda M., Watanabe S., Murakami S., Watanabe Y.: Tumor angiogenesis and recurrence in stage I non-small cell lung cancer. Ann. Thorac. Surg. 68: 1034-1038, 1999.
15. Yuan A., Yu C.J., Chen W.J., et al.: Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer. Int. J. Cancer 89: 475-483, 2000.
16. Gabrilovich D.I., Chen H.L., Girgis K.R., et al.: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med. 2: 1096-1103, 1996.
17. Herold-Mende C., Steiner H., Addl T., et al.: Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells. Lab. Invest. 79: 1573-1582, 1999.
18. Skobe M., Rockwell P., Goldstein N., Vosseler S., Fusenig N.E.: Holting angiogenesis suppresses carcinoma cell invasion. Nat. Med. 3: 1222-1227, 1997.
19. Arbiser J.L., Larsson H., Claesson-Welsh L., et al.: Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high expression of VEGF receptors VEGFR-1 and VEGFR-2 in vivo. Am. J. Pathol. 156: 1469-1476, 2000.
20. Baek J., Jang J., Kang C., Chung H., Kim N., Kim K.: Hypoxia- induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis. Oncogene 19: 4621-4631, 2000.
21. Bruns C.J., Liu W., Davis D.W., et al.: Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Cancer 89: 488-499, 2000.
22. Kukk E., Lymboussaki A., Taira S., et al.: VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122: 3829-3837, 1996.
23. Jeltsch M., Kaipainen A., Joukov V., et al.: Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276: 1423-1425, 1997.
24. Ohta Y., Shridhar V., Bright R.K., et al.: VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Br. J. Cancer 81:54-61, 1999.
25. Beasley N.J., Prevo R., Banerji S., et al.: Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res. 62: 1315-1320, 2002.
26. Dadras S.S., Paul T., Bertoncini J., et al.: A novel prognostic indicator for cutaneous melanoma metastasis and survival. Am. J. Path. 162: 1951-1960, 2003.